The effect of sphenopalatine anesthesia in controlling headache after spinal anesthesia.

Evaluation of the Effect of Sphenopalatine Ganglion Block in the Treatment of Post-Dural Puncture Headache (PDPH) in Patients Undergoing Spinal Anesthesia at Allameh Bohlool Gonabadi Hospital

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200501047254N4

Enrollment

Registered

2026-02-04

Start date

2025-09-23

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-dural puncture headache. Other reaction to spinal and lumbar puncture

Interventions

Intervention 1: Intervention group: Performing a sphenopalatine nerve block under the supervision of an anesthesiologist, transnasally, using a cotton swab soaked in 2% lidocaine. Intervention 2: Cont

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Headache after spinal anesthesia Headache severity of at least 4 out of 10 on a visual analog pain scale(VAS) Patients with stable hemodynamic status at the time of treatment Informed consent No history of allergy or hypersensitivity to lidocaine No active infection or inflammation in the facial or nasal area (site of sphenopalatine block) No peripheral or central nervous system diseases that could interfere with outcome assessment No severe cardiovascular diseases or chronic renal and hepatic failure No history of surgery or trauma in the head and face region that would limit the safe performance of the block No prior receipt of alternative treatments for post-dural puncture headache (PDPH), such as epidural blood patch, and no need for supplemental treatments during the study Absence of coagulation disorders No mental or psychological disabilities that impair the ability to cooperate or respond to questionnaires

Exclusion criteria

Exclusion criteria: Unwillingness to continue participating in the research

Design outcomes

Primary

Measure	Time frame
VAS Pain score. Timepoint: Headache measurement before intervention and at 15 and 30 minutes and 1, 2, 4, 6, 8, 12, 24 hours after intervention. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Tachycardia. Timepoint: heart rate measurement before intervention and at 15 and 30 minutes and 1, 2, 4, 6, 8, 12, 24 hours after intervention. Method of measurement: checklist.	—

Contacts

Public ContactFatemeh Pouladkhay

Gonabad University of Medical Sciences

pouladkhay.fatemeh@gmail.com+98 51 5722 3028

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026